NeoStem in-licenses stem cell procedure in Asia
This article was originally published in Scrip
Executive Summary
NeoStem has in-licensed the Asian rights for Regenexx, a process that uses a patient's own stem cells to regenerate joints and bones as an alternative to surgery.